Skip to main content
. 2022 Jun 6;27(8):646–654. doi: 10.1093/oncolo/oyac089

Figure 1.

Figure 1.

(A) Tablular representation of each patient’s hormonal therapy in addition to CDK4/6. (B) Barplot of percentages for each type of CDK4/6 prescribed at RPCCC across time, from 2015-2020.